ArticleFood science & nutrition2026
Association Between Nonalcoholic Fatty Liver Disease and the Dietary Index for Gut Microbiota: A Cross-Sectional Study.
Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emodin Exerts Dual Hepatoprotective/Hepatotoxic Effects Dependent on Metabolic Microenvironment via Gut-Liver Axis Crosstalk: A Multi-Omics Study in MAFLD and Normal Mice.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is defined by excessive hepatic lipid deposition, which is markedly affected by dietary habits and gut microbiota. This study utilizes the Dietary Index for Gut Microbiota (DI-GM), an established tool derived from 106 peer-reviewed studies, to assess the effect of diet on NAFLD. By evaluating foods that modulate microbiota composition, the DI-GM offers a robust framework for examining dietary quality and its connection to NAFLD risk in a large population. This cross-sectional study analyzed data from the National Health and Nutrition Examination Survey (NHANES, 1999-2018) involving 101,316 participants, excluding those under 18, with incomplete data, alternative liver conditions, or excessive alcohol consumption. Finally, 5283 participants were included. NAFLD was identified using the United States Fatty Liver Index (USFLI). DI-GM scores were calculated from two 24-h dietary recall interviews. Multivariate logistic regression and restricted cubic splines (RCS) assessed the DI-GM-NAFLD relationship, adjusting for demographics, lifestyle, and medical history. Subgroup and sensitivity analyses ensured robustness, while ROC curves and DeLong's test compared DI-GM's predictive ability with Healthy Eating Index-2015 (HEI-2015) and Dietary Approaches to Stop Hypertension (DASH). Among 5283 participants, higher DI-GM scores were associated with a 23.8% lower NAFLD risk (OR: 0.762, 95% CI: 0.590-0.986) in the highest versus lowest quartile. RCS analysis confirmed a linear negative association (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.